Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
– Series A financing to advance clinical development of lead candidate RLS-1496 into Phase 1 studies this year in chronic atopic dermatitis and chronic psoriasis. April 22, 2024 05:00 AM Pacific Daylight Time SUNNYVALE, Calif.–(BUSINESS…